Filing Details

Accession Number:
0001209191-18-006467
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-01 16:31:34
Reporting Period:
2018-01-30
Accepted Time:
2018-02-01 16:31:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1691005 Gatti Susanna High C/O Bluebird Bio, Inc.
60 Binney Street
Cambridge MA 02142
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-30 14,794 $68.65 28,512 No 4 M Direct
Common Stock Disposition 2018-01-30 800 $192.49 27,712 No 4 S Direct
Common Stock Disposition 2018-01-30 3,703 $193.74 24,009 No 4 S Direct
Common Stock Disposition 2018-01-30 4,657 $194.65 19,352 No 4 S Direct
Common Stock Disposition 2018-01-30 2,039 $195.57 17,313 No 4 S Direct
Common Stock Disposition 2018-01-30 1,702 $196.63 15,611 No 4 S Direct
Common Stock Disposition 2018-01-30 1,385 $197.61 14,226 No 4 S Direct
Common Stock Disposition 2018-01-30 490 $198.46 13,736 No 4 S Direct
Common Stock Disposition 2018-01-30 697 $199.43 13,039 No 4 S Direct
Common Stock Disposition 2018-01-30 733 $200.88 12,306 No 4 S Direct
Common Stock Disposition 2018-01-30 770 $201.57 11,536 No 4 S Direct
Common Stock Disposition 2018-01-30 204 $202.68 11,332 No 4 S Direct
Common Stock Disposition 2018-01-30 82 $203.60 11,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2018-01-30 14,794 $0.00 14,794 $68.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,206 2026-12-01 No 4 M Direct
Footnotes
  1. This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 18, 2017.
  2. The range in prices for the transaction reported on this line was $192.00 to $192.95. The average weighted price was $192.4927. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The range in prices for the transaction reported on this line was $193.10 to $194.05. The average weighted price was $193.7439. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The range in prices for the transaction reported on this line was $194.10 to $195.05. The average weighted price was $194.6525. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The range in prices for the transaction reported on this line was $195.10 to $196.05. The average weighted price was $195.5667. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. The range in prices for the transaction reported on this line was $196.10 to $197.05. The average weighted price was $196.6339. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. The range in prices for the transaction reported on this line was $197.10 to $198.00. The average weighted price was $197.6065. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  8. The range in prices for the transaction reported on this line was $198.10 to $199.00. The average weighted price was $198.4634. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  9. The range in prices for the transaction reported on this line was $199.10 to $200.05. The average weighted price was $199.4324. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  10. The range in prices for the transaction reported on this line was $200.20 to $201.10. The average weighted price was $200.8812. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  11. The range in prices for the transaction reported on this line was $201.30 to $202.05. The average weighted price was $201.5739. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  12. The range in prices for the transaction reported on this line was $202.40 to $203.00. The average weighted price was $202.6801. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  13. The range in prices for the transaction reported on this line was $203.50 to $203.70. The average weighted price was $203.60. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  14. This option vests over a four-year period at a rate of twenty-five percent (25%) on November 30, 2017, and in 36 equal monthly installments thereafter.